Lenggries, Germany

Maria Sebald

This inventor holds 2 USPTO granted patents, plus 1 CIPO patent. Top assignee: Hoffmann-La Roche Inc.. Active years: 2017-2021.


% Patents Active = 100.0


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2017-2021

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Maria Sebald: Innovator in Antibody Purification

Introduction

Maria Sebald is a prominent inventor based in Lenggries, Germany. She has made significant contributions to the field of immunology, particularly in the purification of antibodies. With a total of 2 patents to her name, her work has advanced the methodologies used in biopharmaceutical production.

Latest Patents

Maria's latest patents focus on a method for the purification of immunoglobulins by ion exchange chromatography. This innovative chromatographic method utilizes a weak ion exchange resin and a single-step elution process for the effective purification of immunoglobulins. Additionally, her patents describe a method for determining the salt concentration necessary for the single-step elution of immunoglobulins from an ion exchange resin.

Career Highlights

Maria is currently employed at Hoffmann-La Roche Inc., where she continues to develop her expertise in antibody purification techniques. Her work has been instrumental in enhancing the efficiency and effectiveness of immunoglobulin purification processes.

Collaborations

Maria has collaborated with notable colleagues, including Roberto Falkenstein and Burkard Kolb. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Maria Sebald's contributions to the field of immunology through her patents and collaborations highlight her role as a leading inventor in antibody purification. Her work continues to impact the biopharmaceutical industry positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…